Collaboration as the key to turning around the drug discovery business (Part 11) – The future
May 11, 2012
The Future of Collaborative Drug Discovery
The prerequisite to enable the efficiencies of integrated specialization, are secure, trusted collaborative platforms. Mechanisms are required that balance allowing maximum collective contributions, with maximum control of intellectual property ownership.
Fortunately, technologies are emerging in this area to allow what was previously impossible, to become routine. Platforms like LinkedIn and Facebook, with rich, flexible privacy and sharing controls, give us insight into the collective efficiencies that are now just within our grasp.
For full context, find the link to each entry of our 12-part series, “Collaboration is the Key to Turning Around the Drug Discovery Business” using the links below:
Especially read Part 9: Collaboration as the key to turning around the drug discovery business – Collaborate Better
P.S. Beyond collaboration as a more enlightened approach to science, here are the top 5 practical reasons collaborative scientists rock with CDD: 5 Reasons Why Collaborative Scientists Use CDD
You can also download the full series “Collaboration as the key to turning around the drug discovery business” by Barry Bunin as a pdf document:
This blog is authored by members of the CDD Vault community. CDD Vault is a hosted drug discovery informatics platform that securely manages both private and external biological and chemical data. It provides core functionality including chemical registration, structure activity relationship, chemical inventory, and electronic lab notebook capabilities!
CDD Vault: Drug Discovery Informatics your whole project team will embrace!